Search Tag: breast cancer
2024 15 Sep
Breast cancer remains the most frequently diagnosed cancer among women worldwide. While mammography has been the cornerstone of breast cancer screening, its one-size-fits-all approach has notable limitations, particularly in women with dense breast tissue and those at higher risk. In recent years, the focus has shifted toward more personalised...Read more
2024 15 Sep
Breast cancer remains the most frequently diagnosed cancer among women worldwide. While mammography has been the cornerstone of breast cancer screening, its one-size-fits-all approach has notable limitations, particularly in women with dense breast tissue and those at higher risk. In recent years, the focus has shifted toward more personalised...Read more
2024 09 Sep
Breast cancer is one of the most prevalent cancers among women worldwide and a leading cause of cancer-related deaths. Among the key factors influencing the prognosis and treatment planning for patients with locally advanced breast cancer (LABC) is the presence of axillary lymph node metastases (ALNMs). Accurate detection of ALNMs is crucial as...Read more
2024 30 Jul
Neoadjuvant chemotherapy (NAC) has significantly transformed the landscape of breast cancer (BC) treatment, offering a pivotal approach to reducing tumour size before surgery. Initially, NAC was predominantly utilised for locally advanced or inflammatory BC cases that were inoperable, with the primary aim of enabling less extensive surgical interventions...Read more
2024 30 Jul
Neoadjuvant chemotherapy (NAC) has significantly transformed the landscape of breast cancer (BC) treatment, offering a pivotal approach to reducing tumour size before surgery. Initially, NAC was predominantly utilised for locally advanced or inflammatory BC cases that were inoperable, with the primary aim of enabling less extensive surgical interventions...Read more
2024 10 Jul
Breast cancer is the most prevalent cancer and the leading cause of cancer-related deaths among women. Incidental breast lesions, found in 0.3% to 7.63% of cases during computed tomography (CT) scans, pose a clinical challenge as 31.0% to 70.0% of these lesions are malignant. Dual-energy CT (DECT) captures data at two energy levels, offering enhanced...Read more
2024 10 Jul
Breast cancer is the most prevalent cancer and the leading cause of cancer-related deaths among women. Incidental breast lesions, found in 0.3% to 7.63% of cases during computed tomography (CT) scans, pose a clinical challenge as 31.0% to 70.0% of these lesions are malignant. Dual-energy CT (DECT) captures data at two energy levels, offering enhanced...Read more
2024 18 Jun
Breast cancer is the most common cancer in women, with significant global incidence and mortality rates. The TNM classification system is crucial for accurately determining the extent and progression of the disease, guiding treatment decisions and improving patient outcomes. Currently, ultrasound is the primary method for assessing axillary lymph...Read more
2024 18 Jun
Breast cancer is the most common cancer in women, with significant global incidence and mortality rates. The TNM classification system is crucial for accurately determining the extent and progression of the disease, guiding treatment decisions and improving patient outcomes. Currently, ultrasound is the primary method for assessing axillary lymph...Read more
2024 12 Jun
Screening mammography guidelines recommend that scans be reviewed by multiple physicians. While mammography has significantly improved breast cancer outcomes, screening programmes add a substantial workload to healthcare workers who are already facing shortages. There is considerable interest in using artificial intelligence (AI) to address this...Read more
2024 12 Jun
Screening mammography guidelines recommend that scans be reviewed by multiple physicians. While mammography has significantly improved breast cancer outcomes, screening programmes add a substantial workload to healthcare workers who are already facing shortages. There is considerable interest in using artificial intelligence (AI) to address this...Read more
2024 12 Jun
Screening mammography guidelines recommend that scans be reviewed by multiple physicians. While mammography has significantly improved breast cancer outcomes, screening programmes add a substantial workload to healthcare workers who are already facing shortages. There is considerable interest in using artificial intelligence (AI) to address this...Read more
2024 29 May
Contrast-enhanced mammography (CEM) is a promising breast imaging method utilising iodinated contrast material and low- and high-energy images to highlight hypervascular lesions. Recent research indicates high diagnostic performance in breast cancer detection, especially when interpreting both types of images together, with sensitivity and specificity...Read more
2024 29 May
Contrast-enhanced mammography (CEM) is a promising breast imaging method utilising iodinated contrast material and low- and high-energy images to highlight hypervascular lesions. Recent research indicates high diagnostic performance in breast cancer detection, especially when interpreting both types of images together, with sensitivity and specificity...Read more
2024 30 Apr
Breast cancer is a significant global health concern, with over 2 million new cases diagnosed annually worldwide and nearly 8 million cases existing within a 5-year span. In Europe, it is the most prevalent cancer among women, comprising 15% of new cases overall and 30% among women specifically. Over half a million new cases are diagnosed annually...Read more
2024 19 Apr
Q: I had my first mammogram this year and was told that everything was fine, but the radiologist sent me a letter saying that I have dense breast tissue. What does this mean, and should I be worried? A: The short answer is no. Dense breast tissue by itself does not need to cause alarm. Actually, approximately 40% to 50% of women undergoing...Read more
2024 18 Apr
The stiffness of triple-negative breast tumours influences the aggressiveness of cancer cells and their ability to spread to other organs, according to research from the Garvan Institute of Medical Research. Soft tumour environments prime cancer cells for survival during metastasis by triggering an alternative form of metabolism. A recent study...Read more
2024 18 Apr
The stiffness of triple-negative breast tumours influences the aggressiveness of cancer cells and their ability to spread to other organs, according to research from the Garvan Institute of Medical Research. Soft tumour environments prime cancer cells for survival during metastasis by triggering an alternative form of metabolism. A recent study...Read more
2024 11 Apr
A recent study published in Cancer Discovery has provided groundbreaking insights into the mechanisms behind breast cancer relapse, revealing how cancer cells can enter a dormant state to evade treatment and later re-emerge, causing a relapse that is more challenging to manage. Led by researchers at The Institute of Cancer Research, London,...Read more
2024 05 Apr
Researchers Dr Rosa Di Micco & Professor Oreste Gentilini A groundbreaking study presented at the 14th European Breast Cancer Conference showcased the potential benefits of using a combined positron emission tomography-magnetic resonance imaging (PET-MRI) scanning technique in the treatment of early-stage breast cancer. Conducted by Dr...Read more
2024 05 Apr
Researchers Dr Rosa Di Micco & Professor Oreste Gentilini A groundbreaking study presented at the 14th European Breast Cancer Conference showcased the potential benefits of using a combined positron emission tomography-magnetic resonance imaging (PET-MRI) scanning technique in the treatment of early-stage breast cancer. Conducted by Dr...Read more
2024 04 Apr
A team of medical professionals has created a sophisticated artificial intelligence (AI) tool capable of forecasting the likelihood of breast cancer patients experiencing adverse effects post-treatment. Annually, approximately 2 million women receive a breast cancer diagnosis, making it the predominant cancer affecting women in many nations. While...Read more
2024 02 Apr
The European Society for Medical Oncology (ESMO) that the 2024 ESMO Breast Cancer Award is conferred to Hope S. Rugo, Professor of Medicine and Winterhof Family Professor of Breast Cancer at the University of California San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center. Her research interests include novel therapies...Read more
2024 25 Mar
Interpretability is crucial for the ethical use of AI in radiology and is likely to be mandated by regulations in the US and Europe. Many advanced AI algorithms in radiology are black boxes, leading to potential overreliance and incorrect diagnoses. Current clinical risk prediction models for breast cancer often overlook mammography image data,...Read more
2024 19 Mar
Radial scars are mammary lesions characterised by a fibroelastotic core and radiating ducts and lobules. They are primarily detected on mammography, often as architectural distortion, with increasing identification due to digital breast tomosynthesis (DBT). Surgical excision has historically been recommended due to variable upstaging rates, but...Read more
2024 19 Mar
Radial scars are mammary lesions characterised by a fibroelastotic core and radiating ducts and lobules. They are primarily detected on mammography, often as architectural distortion, with increasing identification due to digital breast tomosynthesis (DBT). Surgical excision has historically been recommended due to variable upstaging rates, but...Read more